APA (7th ed.) Citation

SE, M., E, H., & Z, H. (2020). Sustained virologic suppression with abacavir, emtricitabine, and crushed dolutegravir and tenofovir alafenamide in a patient with HIV and eosinophilic esophagitis. International journal of STD & AIDS, 31(3), 285. https://doi.org/10.1177/0956462419895690

Chicago Style (17th ed.) Citation

SE, Moore, Huesgen E, and Howe Z. "Sustained Virologic Suppression with Abacavir, Emtricitabine, and Crushed Dolutegravir and Tenofovir Alafenamide in a Patient with HIV and Eosinophilic Esophagitis." International Journal of STD & AIDS 31, no. 3 (2020): 285. https://doi.org/10.1177/0956462419895690.

MLA (9th ed.) Citation

SE, Moore, et al. "Sustained Virologic Suppression with Abacavir, Emtricitabine, and Crushed Dolutegravir and Tenofovir Alafenamide in a Patient with HIV and Eosinophilic Esophagitis." International Journal of STD & AIDS, vol. 31, no. 3, 2020, p. 285, https://doi.org/10.1177/0956462419895690.